2315
HKSE:2315
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
- Stock
locale
China
market
STOCKSindustry
Biotechnologywebsite
biocytogen.com.cnipo date
Sep 01, 2022
Biocytogen Pharmaceuticals (Beijing) Co., Ltd., a biotechnology company, engages in the research and development of antibody-based drugs worldwide. The company's pipeline includes 12 core products, among which two products are in Phase II multi-regional clinical trials and two products are in Phase I clinical trials. It focuses on developing drugs in the areas of oncology, auto...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus